| C1QBP |
C1QBP, GC1QBP, HABP1, SF2P32: Complement component 1 Q subcomponent-binding prot |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
0.41 |
Evidence |
|
| GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
C10orf9 |
CCNY, C10orf9, CBCP1, CFP1: Cyclin-Y |
0.41 |
Evidence |
|
| GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
SFRS9 |
SFRS9, SRP30C: Splicing factor, arginine/serine-rich 9 |
0.41 |
Evidence |
|
| EWSR1 |
EWSR1, EWS: RNA-binding protein EWS |
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
0.41 |
Evidence |
|
| TUBA1 |
TUBA4A, TUBA1: Tubulin alpha-4A chain |
PTPRC |
PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ |
0.41 |
Evidence |
|
| RAB5B |
RAB5B: Ras-related protein Rab-5B |
RAD18 |
RAD18, RNF73: E3 ubiquitin-protein ligase RAD18 |
0.41 |
Evidence |
|
| AQP4 |
AQP4: Aquaporin-4 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
0.41 |
Evidence |
|
| THOP1 |
THOP1: Thimet oligopeptidase |
RAD18 |
RAD18, RNF73: E3 ubiquitin-protein ligase RAD18 |
0.41 |
Evidence |
|
| RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
0.41 |
Evidence |
|
| RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
0.41 |
Evidence |
|
| PSEN1 |
PSEN1, AD3, PS1, PSNL1: Presenilin-1 |
EIF4G2 |
EIF4G2, DAP5, OK/SW-cl.75: Eukaryotic translation initiation factor 4 gamma 2 |
0.41 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
PSEN1 |
PSEN1, AD3, PS1, PSNL1: Presenilin-1 |
0.41 |
Evidence |
|
| TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
ZFPM1 |
ZFPM1, FOG1: Zinc finger protein ZFPM1 |
0.41 |
Evidence |
|
| TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
TFAP4 |
TFAP4: Transcription factor AP-4 |
0.41 |
Evidence |
|
| TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
MAX |
MAX: Protein max |
0.41 |
Evidence |
|
| ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
EP300 |
IPI00478752 |
0.41 |
Evidence |
|
| ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
NUP153 |
IPI00514528 |
0.41 |
Evidence |
|
| ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
LEF1 |
LEF1: Lymphoid enhancer-binding factor 1 |
0.41 |
Evidence |
|
| ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
PCAF |
PCAF: Histone acetyltransferase PCAF |
0.41 |
Evidence |
|
| ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
SKIIP |
SNW1, SKIIP, SKIP: SNW domain-containing protein 1 |
0.41 |
Evidence |
|
| ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
0.41 |
Evidence |
|
| ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
SFRS4 |
SFRS4, SRP75: Splicing factor, arginine/serine-rich 4 |
0.41 |
Evidence |
|
| ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
0.41 |
Evidence |
|
| ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
TCF8 |
ZEB1, AREB6, TCF8: Zinc finger E-box-binding homeobox 1 |
0.41 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
0.41 |
Evidence |
|